Company Search:
Advanced Search
Sponsored Links
Orexo Ab Company Snapshot
Orexo Ab operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Orexo Ab with three other pharmaceutical manufacturers in Europe: Eco Animal Health Group Plc of the United Kingdom (2017 sales of £61.42 million [US$79.67 million] ), COSMO Pharmaceuticals SA of Italy (67.24 million Euro [US$75.89 million] ), and Antibiotice SA which is based in Romania (336.90 million Romanian Leu [US$81.64 million] ).

Sales Analysis. During the year ended December of 2017, sales at Orexo Ab were SEK 643.70 million (US$71.10 million). This is a decrease of 8.8% versus 2016, when the company's sales were SEK 705.90 million. Contributing to the drop in overall sales was the 91.5% decline in Zubsolv Non Us Upfront Payment, from SEK 65.90 million to SEK 5.60 million. There were also decreases in sales in Other Revenue/ R&d (down 46.6% to SEK 21.80 million) . However, these declines were partially offset by the increase in sales of Zubsolv (up 0.8% to SEK 485.80 million) and Royalty - Abstral (up 12.7% to SEK 113.20 million) and Royalty - Edluar (up 16.9% to SEK 17.30 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Orexo Ab
  Stock Performance Chart for Orexo Ab
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 64.00
(Figures in Swedish Kronor)
1 Week 2.9%   13 Weeks 3.2%  
4 Weeks 35.3%   52 Weeks 50.6%  
Orexo Ab Key Data:
  Ticker: ORX Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 643,700,000
(Year Ending Jan 2018).
Employees: 90
  Currency: Swedish Kronor Market Cap: 2,213,204,928
  Fiscal Yr Ends: December Shares Outstanding: 34,581,327
  Share Type: Aktie Closely Held Shares: 4,164,377
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.